Panel Says Generic Drug Launch Does Not Violate Patent Settlement

Mealey's (July 17, 2019, 12:35 PM EDT) -- PHILADELPHIA — A Delaware federal judge’s “thoughtful and thorough” decision rejecting breach of contract claims levied against a generic drug maker was affirmed July 16 by the Third Circuit U.S. Court...
To view the full article, register now.